Koyfin Home > Directory > Health Care > Kura Oncology > Levered Free Cash Flow (FCF)

Kura Oncology Levered Free Cash Flow (FCF) Chart (KURA)

Kura Oncology annual/quarterly Levered Free Cash Flow (FCF) from 2015 to 2020.
  • Kura Oncology Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-9m a 18.83% decrease of -2m year over year
  • Kura Oncology Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-36m a 18.34% decrease of -7m year over year
  • Kura Oncology Annual Levered Free Cash Flow (FCF) for 2019 was $-32m a 16.58% decrease of -5m from 2018
  • Kura Oncology Annual Levered Free Cash Flow (FCF) for 2018 was $-27m a 40.57% decrease of -11m from 2017
  • Kura Oncology Annual Levered Free Cash Flow (FCF) for 2017 was $-16m a 3.03% decrease of 0m from 2016
Other Cash Flow Metrics:
  • Kura Oncology Cash Flow from Operations for the quarter ending December 12, 2018 was $-10m a -25.85% increase of 3m year over year
View Chart On Koyfin

Quarterly KURA Levered Free Cash Flow (FCF) Data

06/2020$-9m
03/2020$-13m
12/2019$-7m
09/2019$-7m
06/2019$-9m
03/2019$-9m
12/2018$-4m
09/2018$-8m
06/2018$-7m
03/2018$-7m

Annual KURA Levered Free Cash Flow (FCF) Data

2019$-32m
2018$-27m
2017$-16m
2016$-15m
2015$-10m